BG
MR

BlackRock Group’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

BlackRock Group’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-13,306
Closed -$361K – 3087
2015
Q4 		$361K Hold
13,306
– – ﹤0.01% 2320
2015
Q3 		$291K Buy
13,306
+5,091
+62% +$130K ﹤0.01% 2409
2015
Q2 		$234K Sell
8,215
-477,679
-98% -$13.9M ﹤0.01% 2535
2015
Q1 		$13.3M Sell
485,894
-109,705
-18% -$3.02M 0.01% 890
2014
Q4 		$15.7M Buy
595,599
+8,184
+1% +$240K 0.01% 856
2014
Q3 		$17.7M Buy
587,415
+12,210
+2% +$378K 0.01% 825
2014
Q2 		$18.1M Buy
575,205
+159,067
+38% +$5.05M 0.01% 821
2014
Q1 		$13.5M Buy
416,138
+34,335
+9% +$1.2M 0.01% 858
2013
Q4 		$13.9M Buy
381,803
+332,245
+670% +$12.9M 0.01% 839
2013
Q3 		$1.93M Sell
49,558
-279,550
-85% -$11.3M ﹤0.01% 1492
2013
Q2 		$12.3M Buy
+329,108
New +$13M 0.01% 807

Other funds holding MR

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BlackRock Group's MR Position: Q1 2016 in Review

BlackRock Group sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 13,306 shares — an estimated $361K sold.

BlackRock Group first reported a position in MR in Q2 2013 and held it in 11 quarters. The position peaked at $18.1M in Q2 2014. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

  • BlackRock Group reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
  • BlackRock Group sold 13,306 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $361K.
  • BlackRock Group first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 11 quarters.
  • BlackRock Group's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $18.1M in Q2 2014.
  • 2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on BlackRock Group's 13F filing for Q1 2016, filed 10 May 2016.